[
  {
    "ticker": "MPP",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02964021",
    "id": "02964021",
    "pages": 2,
    "price_sensitive": true,
    "date": "20250701",
    "time": "0731",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250701/pdf/06l9932r1ktnvl.pdf",
    "summary": "<p><strong>Capital Raising Announcement:</strong><br />\n- <strong>Structure:</strong> Renounceable rights issue ($9m) + Placement to Amari Metals ($6m+), with oversubscription facility.<br />\n- <strong>Total Raised:</strong> Minimum $15m, maximum $24m at $0.03/share.<br />\n- <strong>Key Dates:</strong> Shareholder meeting expected late August 2025; offer documents to be sent early August 2025.<br />\n- <strong>New Shareholder:</strong> Amari Metals to own 51.0% post-completion.<br />\n- <strong>New Loan Facility:</strong> 3-year facility agreed (terms aligned with current facility); current facilities extended to 30 September 2025.<br />\n- <strong>Conditions:</strong> Shareholder approval, cross-completion, and customary terms.  </p>\n<p><strong>Governance Changes:</strong><br />\n- Amari to appoint Stephen Robertson as non-independent director post-transaction, with potential for a second nominee if ownership \u226540%.  </p>\n<p><strong>Material Impact:</strong><br />\n- Recapitalization and new majority ownership expected to strengthen financial position and operational momentum.</p>",
    "usage": {
      "prompt_tokens": 1161,
      "completion_tokens": 212,
      "total_tokens": 1373,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-06-30T21:59:54.177390"
  },
  {
    "ticker": "AFP",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02964020",
    "id": "02964020",
    "pages": 4,
    "price_sensitive": false,
    "date": "20250701",
    "time": "0731",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250701/pdf/06l990zgn71gvv.pdf",
    "summary": "<ul>\n<li><strong>Combogesic IV (Maxigesic IV) launching in Canada</strong> this month via AFT's new Canadian subsidiary (targeting non-opioid pain management market).  </li>\n<li><strong>Extended US licensing agreement with Hikma Pharmaceuticals</strong> for Maxigesic IV (Combogesic IV) and tablet form (Combogesic Rapid), restructuring profit share to quarterly payments.  </li>\n<li><strong>R&amp;D progress</strong>:  </li>\n<li>Pre-IND filed with FDA for antibiotic eyedrop (targeting resistant infections); IND filing expected by year-end.  </li>\n<li>Pre-IND planned for topical Strawberry Birthmarks treatment in 2025.  </li>\n<li>IND planned for novel iron injection by end-2025.  </li>\n<li>Pipeline now includes 14 projects, 5 nearing commercialization.  </li>\n<li><strong>Paediatric study for Maxigesic IV</strong> to begin, expanding addressable market.  </li>\n<li><strong>Five out-licensing deals completed</strong> this quarter; additional agreements under negotiation.  </li>\n</ul>\n<p><em>No material financial data (e.g., cash balance) or capital-raising details provided.</em></p>",
    "usage": {
      "prompt_tokens": 2424,
      "completion_tokens": 219,
      "total_tokens": 2643,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-06-30T22:00:12.181847"
  },
  {
    "ticker": "AIA",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02964018",
    "id": "02964018",
    "pages": 1,
    "price_sensitive": false,
    "date": "20250701",
    "time": "0730",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250701/pdf/06l98wrcx6pw71.pdf",
    "summary": "<p>Understood. Please provide the <strong>ASX announcement PDF</strong> you'd like analyzed, and I will extract only the material information relevant for trading or capital markets decisions, formatted as strictly concise bullet points according to your specified guidelines.  </p>\n<p><strong>Examples of expected outputs based on your criteria:</strong>  </p>\n<ol>\n<li><strong>Trading Halt Request</strong>  </li>\n<li>\n<p><em>Reason</em>: Pending release of material acquisition announcement.  </p>\n</li>\n<li>\n<p><strong>Capital Raising Announcement</strong>  </p>\n</li>\n<li><em>Type</em>: Placement + SPP  </li>\n<li><em>Amount</em>: $50M (Placement $40M, SPP $10M)  </li>\n<li>\n<p><em>Key Dates</em>: Ex-date \u2013 15/04/2024, SPP Close \u2013 30/04/2024  </p>\n</li>\n<li>\n<p><strong>Appendix 4C (Quarterly Report)</strong>  </p>\n</li>\n<li><em>Cash Balance</em>: $12.5M (QoQ -$2.1M)  </li>\n<li>\n<p><em>Key Highlights</em>: Revenue $8.2M (+15% QoQ), net operating cash outflow $1.4M  </p>\n</li>\n<li>\n<p><strong>Other Material Announcement</strong>  </p>\n</li>\n<li><em>Key Points</em>:<br />\n     \u2022 Major asset sale for $75M (30% premium to book).<br />\n     \u2022 CEO resignation effective immediately, no succession plan disclosed.  </li>\n</ol>\n<p><strong>Note:</strong> If the document lacks material trading or capital markets information, I will reply with:<br />\n- <em>No material information identified</em>.  </p>\n<p>Please share the PDF or key details from the announcement, and I will parse it accordingly.</p>",
    "usage": {
      "prompt_tokens": 220,
      "completion_tokens": 316,
      "total_tokens": 536,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-06-30T21:59:29.984888"
  },
  {
    "ticker": "CNU",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02964019",
    "id": "02964019",
    "pages": 4,
    "price_sensitive": false,
    "date": "20250701",
    "time": "0730",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250701/pdf/06l98yw68lrr7b.pdf",
    "summary": "<p><strong>Capital Structure Update: Redemption of Crown Funding Securities</strong>  </p>\n<ul>\n<li><strong>Redemption of CIP1 Equity Securities</strong>: 85,341,018 unquoted securities redeemed at NZ$1.00 each (total NZD <strong>85.3m</strong>).  </li>\n<li><strong>Cancellation of CIP1 Warrants</strong>: 7,561,881 unquoted warrants cancelled (nil consideration).  </li>\n<li><strong>Debt Repayment</strong>: NZD <strong>85.3m</strong> of unquoted CIP1 debt securities repaid.  </li>\n<li><strong>Impact on Outstanding Securities</strong>:  </li>\n<li>Remaining CIP1 Equity Securities: 376,711,053 (unquoted).  </li>\n<li>Remaining CIP1 Warrants: 9,903,147 (unquoted).  </li>\n<li><strong>Reason</strong>: Mandatory redemption triggered by dividend eligibility under original UFB1 Subscription Agreement.  </li>\n</ul>\n<p><em>No material trading liquidity impact (unquoted securities).</em></p>",
    "usage": {
      "prompt_tokens": 1794,
      "completion_tokens": 189,
      "total_tokens": 1983,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-06-30T22:00:05.501100"
  },
  {
    "ticker": "IFT",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02964017",
    "id": "02964017",
    "pages": 6,
    "price_sensitive": false,
    "date": "20250701",
    "time": "0730",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250701/pdf/06l98tml9jndtl.pdf",
    "summary": "<ul>\n<li><strong>Dividend Reinvestment Plan (DRP) Strike Price</strong>: NZD 10.42983548 per share (FY2025 final dividend)  </li>\n<li><strong>Dividend Details</strong>:  </li>\n<li><strong>Type</strong>: Ordinary, unfranked  </li>\n<li><strong>Amount</strong>: NZD 0.1325 per share (~AUD 0.1229)  </li>\n<li><strong>Ex-Date</strong>: 11/6/2025  </li>\n<li><strong>Record Date</strong>: 12/6/2025  </li>\n<li><strong>Payment Date</strong>: 2/7/2025  </li>\n<li><strong>DRP Key Dates</strong>:  </li>\n<li><strong>Election Deadline</strong>: 13/6/2025 (15:00 NZ time)  </li>\n<li><strong>Price Calculation Period</strong>: 16/6/2025 to 30/6/2025 (10-day NZX VWAP)  </li>\n<li><strong>DRP Discount</strong>: 2.0% (applied to strike price)  </li>\n<li><strong>Eligibility</strong>: NZ/Australian-resident shareholders (address on register).  </li>\n</ul>\n<p><em>No other material trading/capital markets impacts identified.</em></p>",
    "usage": {
      "prompt_tokens": 2312,
      "completion_tokens": 231,
      "total_tokens": 2543,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-06-30T21:59:34.534414"
  }
]